MedPath

Proper Extent of Maze Intercaval Lesion

Withdrawn
Conditions
Atrial Fibrillation
Registration Number
NCT03091205
Lead Sponsor
Baylor Research Institute
Brief Summary

It's hypothesized that a mean and range distance from the cavo-atrial junction to the area where there is complete loss of conductive tissue can be measured to better inform surgeons performing the Cox-Maze procedure. A patient scheduled for any cardiac surgery where visualization and mapping of cavo-atrial junction is possible could be entered into the study if they meet the inclusion/exclusion requirements.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Age ≥ 18 years male or female
  • Scheduled for any cardiac surgery where visualization and mapping of cavo-atrial junction is possible
  • Subjects willing and able to provide written informed consent
Exclusion Criteria
  • Subjects receiving surgery with non-sternotomy access
  • Presence of or history of transvenous pacing leads
  • Subjects receiving a re-do cardiac surgery
  • Subjects with a history of pericarditis
  • Subjects who are in atrial fibrillation or atrial flutter and cannot be converted out of it.
  • Any medical condition or finding for which the Investigator used medical discretion to determine the subject should be excluded
  • Subject is currently participating in another clinical trial.
  • Subject is unable to provide written informed consent.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Distance until complete loss of conductive tissue6 Months

To measure the mean and range distance from the cavo-atrial junction to the area where there is complete loss of conductive tissue.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The Heart Hospital Baylor Plano

🇺🇸

Plano, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath